Competitive Landscape of COVID-19 Therapies

Objective :

COVID-19 developmental pipeline assessment, identifying key competitors, and evaluating emerging therapies in the domain.

Problem Statement:

A mid-sized EU-based firm involved DelveInsight in assessing the developmental pipeline of COVID-19 to assess the competitors across the clinical development pipeline. They wished to identify and evaluate emerging therapies, key competitors and assess the landscape based on the mechanism of action, route of administration, and others of the emerging candidates.

Our Methodology:

Therapeutic R&D Developmental Pipeline Assessment
Assessment of the Drugs
Key Pharmaceuticals Portfolio Assessment
Strategic Planning Assistance

Results:

Detailed profiling of Active Products in the Pipeline
Landscape analysis of various Mechanisms of Action and Routes of Administration
Matrix Analysis positioned the top 10 Companies researched.
The client can appraise all the top companies that can serve as a potential competition

Related case Studies

Market Assessment Asset Prioritization Epidemiology Assessment Product Assessment CDMO Competitive Assessment in the USA and Europe Competitive Intelligence Market & Competitive Assessment

Sample Visuals

Get Visuals

Related Insights

Market Assessment

A global pharmaceutical company wished to evaluate the market value of an asset obtained by acquiring a mid-cap company. The new class of drug showed the potential in targeting multiple... [...]

View Case

Asset Prioritization

A mid-sized pharma client was working to develop their asset portfolio, and was interested to assess best possible asset for atrial fibrillation [...]

View Case

Epidemiology Assessment

A client based in the US wanted the epidemiology assessment exercise to understand the percentage of solid organ transplant recipients who develop Cutaneous Squamous Cell Carcinoma... [...]

View Case